Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

June 30, 2027

Conditions
Labor Pain
Interventions
BEHAVIORAL

Intermittent midwife absence during remote monitoring of remifentanil PCA in labour

"Midwife absence during remifentanil PCA for labour analgesia.~We aim to include a total of 80 participants. All will receive remifentanil PCA for labour analgesia and be monitored with remote monitoring equipment. First a group of 40 parturients will be included, and the attending midwife will not be allowed to leave the parturient (Group 1). A following group of 40 parturients will then be included and the attending midwife can leave the room in intervals up to 10 minutes (Group 2)."

Trial Locations (1)

3400

University Hospital of Copenhagen, Northern Zealand, Hillerød

All Listed Sponsors
lead

Nordsjaellands Hospital

OTHER

NCT07167498 - Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil | Biotech Hunter | Biotech Hunter